Stem cell therapy ameliorates bladder dysfunction in an animal model of parkinson disease

Journal of Urology

Volumn 187, Issue 4, 2012, Pages 1491-1497

  Soler, Roberto ^a,b   Fllhase, Claudius ^a,c   Hanson, Ariel ^a   Campeau, Lysanne ^a   Santos, Cesar ^a,d   Andersson, Karl Erik ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

neural pathways; oxidopamine; Parkinson disease; stem cells; urinary bladder

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 6; OXIDOPAMINE; SUPEROXIDE DISMUTASE;

AMNIOTIC FLUID CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CAPACITY; BLADDER DYSFUNCTION; BLADDER PRESSURE; BONE MARROW CELL; CELL SURVIVAL; CONTROLLED STUDY; CYSTOMETRY; DISEASE ASSOCIATION; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; MICTURITION; NEUROMODULATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; PARKINSON DISEASE; RATS; RATS, NUDE; STEM CELL TRANSPLANTATION; URINARY BLADDER DISEASES;

EID: 84858709082     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.11.079     Document Type: Article

References (30)

1. D.J. Moore, A.B. West, V.L. Dawson Molecular pathophysiology of Parkinson's disease Annu Rev Neurosci 28 2005 57
2. W. Dauer, S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889
3. R. Sakakibara, T. Uchiyama, T. Yamanishi Bladder and bowel dysfunction in Parkinson's disease J Neural Transm 115 2008 443
4. L. Campeau, R. Soler, K.E. Andersson Bladder dysfunction and Parkinsonism: current pathophysiological understanding and management strategies Curr Urol Rep 12 2011 396
5. A.K. Meyer, M. Maisel, A. Hermann Restorative approaches in Parkinson's disease: which cell type wins the race? J Neurol Sci 289 2010 93
6. J.H. Kim, J.M. Auerbach, J.A. Rodriguez-Gomez Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease Nature 418 2002 50
7. M.A. Hellmann, H. Panet, Y. Barhum Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents Neurosci Lett 395 2006 124
8. L. Cova, M.T. Armentero, E. Zennaro Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease Brain Res 1311 2010 12
9. A.E. Donaldson, J. Cai, M. Yang Human amniotic fluid stem cells do not differentiate into dopamine neurons in vitro or after transplantation in vivo Stem Cells Dev 18 2009 1003
10. M. Wernig, J.P. Zhao, J. Pruszak Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease Proc Natl Acad Sci U S A 105 2008 5856
11. Y. Jiang, B.N. Jahagirdar, R.L. Reinhardt Pluripotency of mesenchymal stem cells derived from adult marrow Nature 418 2002 41
12. P. De Coppi, G. Bartsch Jr, M.M. Siddiqui Isolation of amniotic stem cell lines with potential for therapy Nat Biotechnol 25 2007 100
13. L. Crigler, R.C. Robey, A. Asawachaicharn Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis Exp Neurol 198 2006 54
14. L. Perin, S. Sedrakyan, S. Giuliani Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis PLoS One 5 2010 e9357
15. R. Soler, C. Fllhase, C. Santos Development of bladder dysfunction in a rat model of dopaminergic brain lesion Neurourol Urodyn 30 2011 188
16. N. Klages, R. Zufferey, D. Trono A stable system for the high-titer production of multiply attenuated lentiviral vectors Mol Ther 2 2000 170
17. G. Paxinos, C. Watson The Rat Brain in Stereotaxic Coordinates 5th ed. 2005 Academic Press San Diego
18. D. Kirik, C. Rosenblad, A. Bjorklund Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat Exp Neurol 152 1998 259
19. F. Blandini, G. Levandis, E. Bazzini Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model Eur J Neurosci 25 2007 397
20. H. Yuan, S. Sarre, G. Ebinger Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease J Neurosci Methods 144 2005 35
21. G. Xia, P. Ji, O. Rutgeerts Immunomodulatory effects of pretransplant donor blood transfusion on T-cell-independent xenoreactive immunity Transplantation 69 2000 1695
22. H. Okano, M. Sakaguchi, K. Ohki Regeneration of the central nervous system using endogenous repair mechanisms J Neurochem 102 2007 1459
23. M. Penkowa, M. Giralt, N. Lago Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury Exp Neurol 181 2003 130
24. X.Z. Li, L.M. Bai, Y.P. Yang Effects of IL-6 secreted from astrocytes on the survival of dopaminergic neurons in lipopolysaccharide-induced inflammation Neurosci Res 65 2009 252
25. P.A. Walker, M.T. Harting, F. Jimenez Direct intrathecal implantation of mesenchymal stromal cells leads to enhanced neuroprotection via an NFkappaB-mediated increase in interleukin-6 production Stem Cells Dev 19 2010 867
26. P.I. Moreira, X. Zhu, X. Wang Mitochondria: a therapeutic target in neurodegeneration Biochim Biophys Acta 1802 2010 212
27. A. Valle-Prieto, P.A. Conget Human mesenchymal stem cells efficiently manage oxidative stress Stem Cells Dev 19 2010 1885
28. K. Kemp, K. Hares, E. Mallam Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival J Neurochem 114 2009 1569
29. M.J. Chiocco, B.K. Harvey, Y. Wang Neurotrophic factors for the treatment of Parkinson's disease Parkinsonism Relat Disord 3 suppl. 2007 S321
30. A. Pascual, M. Hidalgo-Figueroa, J.I. Piruat Absolute requirement of GDNF for adult catecholaminergic neuron survival Nat Neurosci 11 2008 755